GREM1 is a potential biomarker for the progression and prognosis of bladder cancer

被引：0
作者：
Peng-cheng Jiang
Li-zhe Xu
Jin-zhuo Ning
Fan Cheng
机构：
[1] Renmin Hospital of Wuhan University,Department of Urology
来源：
World Journal of Surgical Oncology | / 21卷
关键词：
GREM1; Bladder cancer; Progression; Apoptosis; PI3K/AKT signaling pathway;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 99 条
  • [31] Park SA(2022)Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer Crit Rev Oncol Hematol 176 335-undefined
  • [32] Sung NJ(2018)The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL Blood 132 undefined-undefined
  • [33] Choi BJ(2023)Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer N Engl J Med 388 undefined-undefined
  • [34] Gazzerro E(2018)Targeting the PI3K/AKT/mTOR Pathway in Bladder Cancer Methods Mol Biol 1655 undefined-undefined
  • [35] Smerdel-Ramoya A(undefined)undefined undefined undefined undefined-undefined
  • [36] Zanotti S(undefined)undefined undefined undefined undefined-undefined
  • [37] Church RH(undefined)undefined undefined undefined undefined-undefined
  • [38] Ali I(undefined)undefined undefined undefined undefined-undefined
  • [39] Tate M(undefined)undefined undefined undefined undefined-undefined
  • [40] Myllarniemi M(undefined)undefined undefined undefined undefined-undefined
12345678910